English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists

Heesen, C., Kleiter, I., Nguyen, F., Schäffler, N., Kasper, J., Köpke, S., et al. (2010). Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists. Multiple Sclerosis, 16(12), 1507-1512. doi:10.1177/1352458510379819.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Heesen, Christoph, Author
Kleiter, Ingo, Author
Nguyen, Franziska, Author
Schäffler, Nina, Author
Kasper, Jürgen, Author
Köpke, Sascha, Author
Gaissmaier, Wolfgang1, 2, Author           
Affiliations:
1Center for Adaptive Behavior and Cognition, Max Planck Institute for Human Development, Max Planck Society, ou_2074285              
2Harding Center for Risk Literacy, Max Planck Institute for Human Development, Max Planck Society, ou_2074291              

Content

show

Details

show
hide
Language(s): eng - English
 Dates: 2010
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: eDoc: 532879
DOI: 10.1177/1352458510379819
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Multiple Sclerosis
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 16 (12) Sequence Number: - Start / End Page: 1507 - 1512 Identifier: -